22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, announced today that on October 11, 2018, Dr. Lynn Hull, Lead Pharmacologist at the Food and Drug Administration (FDA) Center for Tobacco Products, held a webcast highlighting and summarizing the published science supporting the FDA’s efforts to dramatically reduce nicotine in all cigarettes sold in the United States.
October 12, 2018
· 8 min read